LIMN
Liminatus Pharma, Inc. Class A Common Stock
Investor Moves
| Investor | Portfolio Value | Portfolio Change | Position Change | Avg Buy Price | Current Price |
|---|---|---|---|---|---|
Ken GriffinCitadel Advisors $-43.3K ExitQ1 2026 $43k -- $0.164 | |||||
Liminatus Pharma, Inc. Class A Common Stock
| Investor | Portfolio Value | Portfolio Change | Position Change | Avg Buy Price | Current Price |
|---|---|---|---|---|---|
Ken GriffinCitadel Advisors $-43.3K ExitQ1 2026 $43k -- $0.164 | |||||
